{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:58:46Z","timestamp":1788188326263,"version":"build-2803163510"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371258"],"award-info":[{"award-number":["82371258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nbd.2026.107316","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:21:09Z","timestamp":1770657669000},"page":"107316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches"],"prefix":"10.1016","volume":"220","author":[{"given":"Jinshuo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peidong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107316_bb0005","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","article-title":"Predictors of nursing home placement in Parkinson\u2019s disease: a population-based, prospective study","volume":"48","author":"Aarsland","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.nbd.2026.107316_bb0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00217-019-03416-8","article-title":"Characterization of phenolic compounds using UPLC\u2013HRMS and HPLC\u2013DAD and anti-cholinesterase and anti-oxidant activities of Trifolium repens L. leaves","volume":"246","author":"Ahmad","year":"2019","journal-title":"Eur. Food Res. Technol."},{"key":"10.1016\/j.nbd.2026.107316_bb0015","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.cub.2018.06.064","article-title":"Basal forebrain and brainstem cholinergic neurons differentially impact amygdala circuits and learning-related behavior","volume":"28","author":"Aitta-Aho","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nbd.2026.107316_bb0020","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awaa243","article-title":"Predictive sensorimotor control in autism","volume":"143","author":"Arthur","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","article-title":"Neurotransmission in Parkinson\u2019s disease: beyond dopamine","volume":"17","author":"Barone","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/0269881105057696","article-title":"Dysregulation of thalamic sensory \u2018transmission\u2019 in schizophrenia: neurochemical vulnerability to hallucinations","volume":"20","author":"Behrendt","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.nbd.2026.107316_bb0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1017\/S0140525X04000184","article-title":"Hallucinations in schizophrenia, sensory impairment, and brain disease: a unifying model","volume":"27","author":"Behrendt","year":"2004","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.nbd.2026.107316_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/mds.27557","article-title":"Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease","volume":"34","author":"Bejr-Kasem","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00702-019-02120-x","article-title":"The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson\u2019s disease and in schizophrenia","volume":"127","author":"Ben-Shachar","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2026.107316_bb0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00702-019-02120-x","article-title":"The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia","volume":"127","author":"Ben-Shachar","year":"2020","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2026.107316_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WNF.0000000000000254","article-title":"Successful use of escitalopram for the treatment of visual hallucinations in patients with Parkinson disease","volume":"40","author":"Bergman","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2026.107316_bb0060","article-title":"Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson\u2019s disease","volume":"9","author":"Bergmans","year":"2023","journal-title":"Clin. Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0065","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s11682-020-00392-6","article-title":"The exploration of Parkinson\u2019s disease: a multi-modal data analysis of resting functional magnetic resonance imaging and gene data","volume":"15","author":"Bi","year":"2020","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.nbd.2026.107316_bb0070","series-title":"Sub-Type Selective Muscarinic Acetylcholine Receptors Modulation for the Treatment of Parkinsonian Tremor","author":"Bickham","year":"2022"},{"key":"10.1016\/j.nbd.2026.107316_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/bs.irn.2018.07.027","article-title":"Molecular imaging of the cholinergic system in Parkinson\u2019s disease","volume":"141","author":"Bohnen","year":"2018","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107316_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac320","article-title":"Progression of regional cortical cholinergic denervation in Parkinson\u2019s disease","volume":"4","author":"Bohnen","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2026.107316_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1474-4422(21)00377-X","article-title":"Cholinergic system changes in Parkinson\u2019s disease: emerging therapeutic approaches","volume":"21","author":"Bohnen","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.parkreldis.2016.04.023","article-title":"Parkinson\u2019s disease, visual hallucinations and apomorphine: a review of the available evidence","volume":"27","author":"Borgemeester","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2023.102548","article-title":"Neuroplasticity in levodopa-induced dyskinesias: an overview on pathophysiology and therapeutic targets","volume":"232","author":"Bove","year":"2024","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107316_bb0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbi.2023.11.004","article-title":"Neuronanomedicine for Alzheimer\u2019s and Parkinson\u2019s disease: current progress and a guide to improve clinical translation","volume":"115","author":"Boyton","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2026.107316_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2008.05.022","article-title":"Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation","author":"Brenner","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2026.107316_bb0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainresbull.2008.08.014","article-title":"Intralaminar nuclei of the thalamus in Lewy body diseases","volume":"78","author":"Brooks","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2026.107316_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tins.2007.03.001","article-title":"Dopamine-mediated regulation of corticostriatal synaptic plasticity","volume":"30","author":"Calabresi","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.119915","article-title":"Characterising stationary and dynamic effective connectivity changes in the motor network during and after tDCS","volume":"269","author":"Calzolari","year":"2023","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2026.107316_bb0125","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/mds.25040","article-title":"Short latency afferent inhibition in Parkinson's disease patients with dementia","volume":"27","author":"Celebi","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00263","article-title":"Cholinergic control of inflammation, metabolic dysfunction, and cognitive impairment in obesity-associated disorders: mechanisms and novel therapeutic opportunities","volume":"13","author":"Chang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154044","article-title":"The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine","volume":"100","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nbd.2026.107316_bb0140","article-title":"Whole-brain mapping of basal forebrain cholinergic neurons reveals a long-range reciprocal input-output loop between distinct subtypes","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.nbd.2026.107316_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.120068","article-title":"Multimodal comparisons of QSM and PET in neurodegeneration and aging","volume":"273","author":"Cogswell","year":"2023","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2026.107316_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00194","article-title":"Striatal dopamine D2-muscarinic acetylcholine M1 receptor\u2013receptor interaction in a model of movement disorders","volume":"11","author":"Crans","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107316_bb0155","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1093\/brain\/awae186","article-title":"Cholinergic deficiency in Parkinson\u2019s disease patients with visual hallucinations","volume":"147","author":"d\u2019Angremont","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0160","article-title":"Distinct grey and white matter changes are associated with the phenomenology of visual hallucinations in Lewy Body Disease","volume":"14","author":"D'Antonio","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107316_bb0165","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1523\/JNEUROSCI.6393-09.2010","article-title":"Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo","volume":"30","author":"Davis","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2024.108640","article-title":"Cross-cultural adaptation and measurement properties of the Brazilian Portuguese version of the Parkinson\u2019s disease sleep scale-2 (PDSS-2)","volume":"247","author":"de Oliveira","year":"2024","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.nbd.2026.107316_bb0175","series-title":"Parkinson\u2019s disease and parkinsonism: neuropathology","first-page":"2","author":"Dickson","year":"2012"},{"key":"10.1016\/j.nbd.2026.107316_bb0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","article-title":"Hallucinations in Parkinson disease","volume":"5","author":"Diederich","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0185","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00415-022-11427-x","article-title":"Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson's disease","volume":"270","author":"Diez-Cirarda","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0190","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107316_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18882-y","article-title":"Polysynaptic inhibition between striatal cholinergic interneurons shapes their network activity patterns in a dopamine-dependent manner","volume":"11","author":"Dorst","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107316_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105699","article-title":"Blockade of M4 muscarinic receptors on striatal cholinergic interneurons normalizes striatal dopamine release in a mouse model of TOR1A dystonia","volume":"168","author":"Downs","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107316_bb0205","first-page":"7","article-title":"Machine learning explains response variability of deep brain stimulation on Parkinson\u2019s disease quality of life","author":"Ferrea","year":"2024","journal-title":"npj Dig. Med."},{"key":"10.1016\/j.nbd.2026.107316_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105263","article-title":"D2R signaling in striatal spiny neurons modulates L-DOPA induced dyskinesia","volume":"25","author":"Florio","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.nbd.2026.107316_bb0215","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A 12-year population-based study of psychosis in Parkinson disease","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.120094","article-title":"Vessel distance mapping: a novel methodology for assessing vascular-induced cognitive resilience","volume":"274","author":"Garcia-Garcia","year":"2023","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2026.107316_bb0225","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/WNL.50.2.515","article-title":"Intravenous levodopa in hallucinating Parkinson\u2019s disease patients: high-dose challenge does not precipitate hallucinations","volume":"50","author":"Goetz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107316_bb0230","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.0b013e3181fd6158","article-title":"Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study","volume":"75","author":"Goetz","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107316_bb0235","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/brain\/awt360","article-title":"Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson\u2019s disease with hallucinations","volume":"137","author":"Goldman","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0240","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11682-019-00247-9","article-title":"Metabolic and amyloid PET network reorganization in Alzheimer's disease: differential patterns and partial volume effects","volume":"15","author":"Gonzalez-Escamilla","year":"2021","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.nbd.2026.107316_bb0245","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3233\/JPD-202116","article-title":"Hallucinations and development of dementia in Parkinson's disease","volume":"10","author":"Gryc","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2026.107316_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154497","article-title":"Traditional Chinese medicine Pingchan granule for motor symptoms and functions in Parkinson's disease: A multicenter, randomized, double-blind, placebo-controlled study","volume":"108","author":"Gu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nbd.2026.107316_bb0255","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awu193","article-title":"Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson\u2019s disease","volume":"137","author":"Hall","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0260","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1162\/netn_a_00078","article-title":"Changes in structural network topology correlate with severity of hallucinatory behavior in Parkinson\u2019s disease","volume":"3","author":"Hall","year":"2019","journal-title":"Netw. Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0265","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1007\/s12035-024-04128-1","article-title":"Unraveling dysregulated cell signaling pathways, genetic and epigenetic mysteries of Parkinson\u2019s disease","volume":"61","author":"Hamidpour","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107316_bb0270","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11655-016-2537-7","article-title":"Traditional Chinese medicine for modern treatment of Parkinson\u2019s disease","volume":"23","author":"Han","year":"2017","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.nbd.2026.107316_bb0275","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0280","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/brain\/awf251","article-title":"Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0285","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41593-022-01162-x","article-title":"GABA facilitates spike propagation through branch points of sensory axons in the spinal cord","volume":"25","author":"Hari","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0290","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.parkreldis.2013.04.026","article-title":"Cognitive correlates of visual hallucinations in non-demented Parkinson\u2019s disease patients","volume":"19","author":"Hepp","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0295","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/NEN.0000000000000014","article-title":"Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients","volume":"72","author":"Hepp","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0300","article-title":"Pre-surgical features of intrinsic brain networks predict single and joint epilepsy surgery outcomes","volume":"38","author":"Hinds","year":"2023","journal-title":"NeuroImage: Clin."},{"key":"10.1016\/j.nbd.2026.107316_bb0305","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-022-00625-4","article-title":"Traditional Chinese medicine syndrome differentiation and treatment by stages of Parkinson\u2019s disease: study protocol for a multicentre, randomized, double-blind, placebo-controlled clinical trial","volume":"17","author":"Hu","year":"2022","journal-title":"Chin. Med."},{"key":"10.1016\/j.nbd.2026.107316_bb0310","first-page":"103","article-title":"Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer\u2019s disease","volume":"4","author":"Hwang","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.nbd.2026.107316_bb0315","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/brain\/awae289","article-title":"Visual hallucinations in Parkinson's disease: spotlight on central cholinergic dysfunction","volume":"148","author":"Ignatavicius","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0320","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.parkreldis.2014.06.018","article-title":"Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations","volume":"20","author":"Jacobson","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2013.11.015","article-title":"Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease","volume":"337","author":"Jang","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107316_bb0330","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00415-011-6149-z","article-title":"The pedunculopontine nucleus is related to visual hallucinations in Parkinson\u2019s disease: preliminary results of a voxel-based morphometry study","volume":"259","author":"Janzen","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105764","article-title":"Prospective approach of Swietenia macrophylla as a neuroprotective agent for Alzheimer\u2019s Disease: emphasis on ameliorative mechanism","volume":"108","author":"Jazuli","year":"2023","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.nbd.2026.107316_bb0340","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2026.107316_bb0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/1546","article-title":"Intrathalamic connections: a new way to modulate cortical plasticity?","volume":"1","author":"Kaas","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0350","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.parkreldis.2008.05.007","article-title":"Dementia and visual hallucinations associated with limbic pathology in Parkinson\u2019s disease","volume":"15","author":"Kalaitzakis","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0355","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1567205013666160930112625","article-title":"Beyond acetylcholinesterase inhibitors: novel cholinergic treatments for Alzheimer\u2019s disease","volume":"14","author":"Kamkwalala","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2026.107316_bb0360","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/brainsci14060556","article-title":"Short-term therapeutic effect of repetitive transcranial magnetic stimulations of sleep disorders in Parkinson\u2019s disease: a randomized clinical trial (pilot study)","volume":"14","author":"Khedr","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.nbd.2026.107316_bb0365","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40478-016-0334-3","article-title":"Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations","volume":"4","author":"Khundakar","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2026.107316_bb0370","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s10548-024-01054-2","article-title":"Clinical and brain morphometry predictors of deep brain stimulation outcome in Parkinson\u2019s disease","volume":"37","author":"Koivu","year":"2024","journal-title":"Brain Topogr."},{"key":"10.1016\/j.nbd.2026.107316_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2023.10.007","article-title":"Brain stimulation targets for chronic pain: Insights from meta-analysis, functional connectivity and literature review","volume":"21","author":"Kong","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2026.107316_bb0380","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1134\/S181971242304013X","article-title":"Induction of the cholinergic phenotype in mouse neuroblastoma cells using nerve growth factor","volume":"17","author":"Koryagina","year":"2023","journal-title":"Neurochem. J."},{"key":"10.1016\/j.nbd.2026.107316_bb0385","article-title":"The structural connectivity mapping of the intralaminar thalamic nuclei","volume":"13","author":"Kumar","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107316_bb0390","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1037\/bne0000625","article-title":"Deep brain stimulation of nucleus basalis of meynert: Effect of stimulation mode and duration on learning in rat model of dementia","volume":"139","author":"Kumbhare","year":"2025","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0395","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1038\/s41380-024-02842-9","article-title":"Cortical hypometabolism in Parkinson\u2019s disease is linked to cholinergic basal forebrain atrophy","volume":"30","author":"Labrador-Espinosa","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107316_bb0400","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1038\/s41380-024-02842-9","article-title":"Cortical hypometabolism in Parkinson\u2019s disease is linked to cholinergic basal forebrain atrophy","volume":"30","author":"Labrador-Espinosa","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107316_bb0405","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1528-1157.2001.21801.x","article-title":"Disparity of perfusion and glucose metabolism of epileptogenic zones in temporal lobe epilepsy demonstrated by SPM\/SPAM Analysis on 15O Water PET, [18F]FDG-PET, and [99mTc]-HMPAO SPECT","volume":"42","author":"Lee","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2026.107316_bb0410","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson\u2019s disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2026.107316_bb0415","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/mds.23368","article-title":"Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease","volume":"25","author":"Li","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0420","first-page":"726","article-title":"Clinical analysis of hallucinations in patients with Parkinson\u2019s disease","volume":"37","author":"Li","year":"2017","journal-title":"Chin. J. Pract. Intern. Med."},{"key":"10.1016\/j.nbd.2026.107316_bb0425","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","article-title":"Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"129","author":"Liu","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107316_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropsychologia.2024.108841","article-title":"Reciprocal interactions among parietal and occipito-temporal representations support everyday object-directed actions","volume":"198","author":"Mahon","year":"2024","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.nbd.2026.107316_bb0435","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3174\/ajnr.A3113","article-title":"Whither the hippocampus? FDG-PET hippocampal hypometabolism in Alzheimer disease revisited","volume":"33","author":"Maldjian","year":"2012","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2026.107316_bb0440","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1007\/s00415-024-12400-6","article-title":"The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson\u2019s disease","volume":"271","author":"Marano","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0445","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s13311-020-00894-7","article-title":"Therapy of Parkinson's disease subtypes","volume":"17","author":"Marras","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2026.107316_bb0450","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neurobiolaging.2022.01.001","article-title":"Limbic thalamus atrophy is associated with visual hallucinations in Lewy body disorders","volume":"112","author":"Matar","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2026.107316_bb0455","series-title":"Membrane Potential Correlates of Network Decorrelation and Improved SNR by Cholinergic Activation in the Somatosensory Cortex","author":"Meir","year":"2017"},{"key":"10.1016\/j.nbd.2026.107316_bb0460","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00702-016-1530-9","article-title":"Structural and functional considerations of the cholinergic brainstem","volume":"123","author":"Mena-Segovia","year":"2016","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2026.107316_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.110967","article-title":"Decreased short-latency afferent inhibition in individuals with mild cognitive impairment: a TMS-EEG study","volume":"132","author":"Mimura","year":"2024","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107316_bb0470","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4682-7-10","article-title":"A thalamic reticular networking model of consciousness","volume":"7","author":"Min","year":"2010","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.nbd.2026.107316_bb0475","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/NEN.0b013e31827c5710","article-title":"Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies","volume":"72","author":"Mukaetova-Ladinska","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0480","first-page":"1027","article-title":"Expert consensus on diagnosis and treatment of depression in Parkinson\u2019s disease with integrated traditional Chinese and Western medicine (2021 edition)","volume":"21","author":"Ning","year":"2021","journal-title":"Chin. J. Contemp. Neurol. Neurosurg."},{"key":"10.1016\/j.nbd.2026.107316_bb0485","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12264-024-01188-0","article-title":"Positron emission tomography imaging of synaptic dysfunction in Parkinson's disease","volume":"40","author":"Niu","year":"2024","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.nbd.2026.107316_bb0490","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuropharm.2005.10.013","article-title":"Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors","volume":"50","author":"Nizri","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2026.107316_bb0495","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.clinph.2017.03.011","article-title":"Olfactory dysfunction in early Parkinson\u2019s disease is associated with short latency afferent inhibition reflecting central cholinergic dysfunction","volume":"128","author":"Oh","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.nbd.2026.107316_bb0500","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40263-024-01084-1","article-title":"On the optimal diagnosis and the evolving role of pimavanserin in Parkinson\u2019s disease psychosis","volume":"38","author":"Pagan","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2026.107316_bb0505","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26432","article-title":"Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase","volume":"31","author":"Pagonabarraga","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0510","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.parkreldis.2005.10.005","article-title":"Cortical and amygdalar Lewy body burden in Parkinson\u2019s disease patients with visual hallucinations","volume":"12","author":"Papapetropoulos","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0515","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/mdc3.13319","article-title":"The cholinergic brain in Parkinson's disease","volume":"8","author":"Pasquini","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.nbd.2026.107316_bb0520","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00702-018-1845-9","article-title":"The striatal cholinergic system in l-dopa-induced dyskinesias","volume":"125","author":"Perez","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2026.107316_bb0525","article-title":"Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease. npj","volume":"2","author":"Perez-Lloret","year":"2016","journal-title":"Parkinson\u2019s Dis."},{"key":"10.1016\/j.nbd.2026.107316_bb0530","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000100850","article-title":"Cognitive changes in Parkinson\u2019s disease patients with visual hallucinations","volume":"23","author":"Ramirez-Ruiz","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0535","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00702-024-02769-z","article-title":"Parkinson's disease and vitamins: a focus on vitamin B12","volume":"131","author":"Rekik","year":"2024","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2026.107316_bb0540","series-title":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","first-page":"1","article-title":"Selective potentiation of muscarinic acetylcholine receptor subtype 1 demonstrates efficacy and safety in preclinical models of Alzheimer\u2019s disease and schizophrenia","author":"Rook","year":"2018"},{"key":"10.1016\/j.nbd.2026.107316_bb0545","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/nan.12294","article-title":"Cortical Lewy bodies and A\u03b2 burden are associated with prevalence and timing of dementia in Lewy body diseases","volume":"42","author":"Ruffmann","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107316_bb0550","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1748-1716.2007.01804.x","article-title":"Nicotinic acetylcholine receptors of adrenal chromaffin cells","volume":"192","author":"Sala","year":"2007","journal-title":"Acta Physiol."},{"key":"10.1016\/j.nbd.2026.107316_bb0555","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00415-019-09657-7","article-title":"Parkinson\u2019s Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life","volume":"267","author":"Scherbaum","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0560","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1093\/brain\/awad226","article-title":"Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease","volume":"146","author":"Schumacher","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0565","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/acn3.446","article-title":"Impaired synaptic function is linked to cognition in Parkinson's disease","volume":"4","author":"Selnes","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0570","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s12035-023-03707-y","article-title":"Classic famous prescription Kai-Xin-San ameliorates Alzheimer\u2019s disease via the Wnt\/\u03b2-Catenin signaling pathway","volume":"61","author":"Shan","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107316_bb0575","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-019-0519-7","article-title":"Visual hallucinations in Alzheimer\u2019s disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas","volume":"11","author":"Sinclair","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.nbd.2026.107316_bb0580","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1176\/appi.neuropsych.21040103","article-title":"Possible contribution of altered cholinergic activity in the visual cortex in visual hallucinations in Parkinson's disease","volume":"34","author":"Sinclair","year":"2022","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"issue":"supplement 1","key":"10.1016\/j.nbd.2026.107316_bb0585","first-page":"1246","article-title":"Comparison of cerebral grey matter atrophy and hypometabolism in posterior cortical atrophy using voxel-based morphometry in MRI and FDG-PET","volume":"52","author":"Song","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2026.107316_bb0590","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0891988715598237","article-title":"Visual priming and visual hallucinations in Parkinson's disease. Evidence for normal top-down processes","volume":"29","author":"Straughan","year":"2016","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0595","first-page":"7","article-title":"Identification of Parkinson\u2019s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data","author":"Su","year":"2024","journal-title":"npj Dig. Med."},{"key":"10.1016\/j.nbd.2026.107316_bb0600","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/brain\/awad305","article-title":"Abnormal higher-order network interactions in Parkinson\u2019s disease visual hallucinations","volume":"147","author":"Tan","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0605","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12149-020-01453-y","article-title":"Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer\u2019s disease","volume":"34","author":"Thientunyakit","year":"2020","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.nbd.2026.107316_bb0610","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1523\/JNEUROSCI.5620-09.2010","article-title":"Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum","volume":"30","author":"Threlfell","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0615","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4306\/pi.2016.13.3.364","article-title":"Visual hallucinations and amyloid deposition in parkinson\u2019s disease dementia: a case report","volume":"13","author":"Um","year":"2016","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.nbd.2026.107316_bb0620","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1755-5949.2010.00166.x","article-title":"Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data","volume":"17","author":"van Laar","year":"2011","journal-title":"CNS Neurosci. Therap."},{"key":"10.1016\/j.nbd.2026.107316_bb0625","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40263-024-01078-z","article-title":"An evidence-based update on anticholinergic use for drug-induced movement disorders","volume":"38","author":"Vanegas-Arroyave","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2026.107316_bb0630","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2017.03.049","article-title":"Impaired cholinergic transmission in patients with Parkinson's disease and olfactory dysfunction","volume":"377","author":"Versace","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107316_bb0635","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41467-022-28087-0","article-title":"Mapping brain structural differences and neuroreceptor correlates in Parkinson's disease visual hallucinations","volume":"13","author":"Vignando","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107316_bb0640","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2017.00010","article-title":"Basal forebrain cholinergic system and orexin neurons: effects on attention","volume":"11","author":"Villano","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0645","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1523\/JNEUROSCI.4647-06.2007","article-title":"Functional characterization of intrinsic cholinergic interneurons in the cortex","volume":"27","author":"von Engelhardt","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107316_bb0650","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1073\/pnas.90.18.8712","article-title":"Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation","volume":"90","author":"Wallace","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107316_bb0655","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cortex.2019.12.023","article-title":"Mind-wandering in Parkinson\u2019s disease hallucinations reflects primary visual and default network coupling","volume":"125","author":"Walpola","year":"2020","journal-title":"Cortex"},{"key":"10.1016\/j.nbd.2026.107316_bb0660","first-page":"1","article-title":"chinese herbal medicine paratherapy for Parkinson's disease: a meta-analysis of 19 randomized controlled trials","volume":"2012","author":"Wang","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.nbd.2026.107316_bb0665","article-title":"A longitudinal electrophysiological and behavior dataset for PD rat in response to deep brain stimulation","volume":"11","author":"Wang","year":"2024","journal-title":"Sci. Data"},{"key":"10.1016\/j.nbd.2026.107316_bb0670","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","article-title":"Visual hallucinations in the diagnosis of idiopathic Parkinson\u2019s disease: a retrospective autopsy study","volume":"4","author":"Williams","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107316_bb0675","doi-asserted-by":"crossref","DOI":"10.1055\/s-2007-992810","article-title":"Prefrontal dopamine signaling in schizophrenia - the corticocentric model","volume":"40","author":"Winterer","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.nbd.2026.107316_bb0680","first-page":"1016","article-title":"Influencing factors of visual hallucinations in patients with Parkinson\u2019s disease and its relationship with sleep disorders","volume":"96","author":"Wu","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.nbd.2026.107316_bb0685","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1002\/hbm.24311","article-title":"Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in (18) F-FDG PET imaging","volume":"39","author":"Wu","year":"2018","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nbd.2026.107316_bb0690","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-981-15-7086-5_8","article-title":"Neural circuits for sleep-wake regulation","volume":"1284","author":"Wu","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2026.107316_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106406","article-title":"Neurovascular coupling alteration in drug-na\u00efve Parkinson's disease: the underlying molecular mechanisms and levodopa's restoration effects","volume":"191","author":"Wu","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107316_bb0700","series-title":"Characteristics of Brain Glucose Metabolism on 18F-FDG PET Imaging in Patients with Early Parkinson's Disease Accompanied by Visuospatial Working Memory Impairment. Zhonghua heyixue yu fenzi yingxiang zazhi","author":"Xiuming","year":"2019"},{"key":"10.1016\/j.nbd.2026.107316_bb0705","article-title":"Effect of acetylcholine deficiency on neural oscillation in a brainstem-thalamus-cortex neurocomputational model related with Alzheimer's disease","volume":"12","author":"Yang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107316_bb0710","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1002\/hbm.22577","article-title":"The default mode network is disrupted in Parkinson\u2019s disease with visual hallucinations","volume":"35","author":"Yao","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nbd.2026.107316_bb0715","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/mds.25360","article-title":"Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson\u2019s disease?","volume":"28","author":"Yarnall","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0720","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2024.02.004","article-title":"Lower oddball event-related EEG delta and theta responses in patients with dementia due to Parkinson's and Lewy body than Alzheimer's disease","volume":"137","author":"Y\u0131ld\u0131r\u0131m","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2026.107316_bb0725","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1883","article-title":"Visual hallucinations and inferior longitudinal fasciculus in Parkinson's disease","volume":"10","author":"Yuki","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.nbd.2026.107316_bb0730","series-title":"iScience, 28 (3), 112001","author":"Varsanyi","year":"2025"},{"key":"10.1016\/j.nbd.2026.107316_bb0735","doi-asserted-by":"crossref","first-page":"e1525","DOI":"10.1212\/WNL.0000000000009014","article-title":"Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction","volume":"94","author":"Zarkali","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107316_bb0740","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/brain\/awaa270","article-title":"Differences in network controllability and regional gene expression underlie hallucinations in Parkinson's disease","volume":"143","author":"Zarkali","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107316_bb0745","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/mds.28477","article-title":"Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson's disease","volume":"36","author":"Zarkali","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107316_bb0750","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1142\/S0192415X14500657","article-title":"Systematic Review of Traditional Chinese Medicine for Depression in Parkinson's Disease","volume":"42","author":"Zhang","year":"2014","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.nbd.2026.107316_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175884","article-title":"Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: a network meta-analysis","volume":"954","author":"Zhang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107316_bb0760","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2022.843303","article-title":"The Mesoscopic Connectome of the Cholinergic Pontomesencephalic Tegmentum","volume":"16","author":"Zhao","year":"2022","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2026.107316_bb0765","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41380-021-01198-8","article-title":"Thalamic reticular nucleus impairments and abnormal prefrontal control of dopamine system in a developmental model of schizophrenia: prevention by N-acetylcysteine","volume":"26","author":"Zhu","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107316_bb0770","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cortex.2021.03.007","article-title":"White matter abnormalities of right hemisphere attention networks contribute to visual hallucinations in dementia with Lewy bodies","volume":"139","author":"Zorzi","year":"2021","journal-title":"Cortex"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:59:44Z","timestamp":1778018384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":154,"alternative-id":["S0969996126000604"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107316","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107316"}}